Triggering receptor expressed on myeloid cells and 5’adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target

References

• Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. 2007 Dec;65:140–146.
   PubMed Web of Science ®Google Scholar
• Cash JL, Norling LV, Perretti M. Resolution of inflammation: targeting GPCRs that interact with lipids and peptides. Drug Discov Today. 2014 Aug;19:1186–1192.
   PubMed Web of Science ®Google Scholar
• Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011 May;31:986–1000.
   PubMed Web of Science ®Google Scholar
• O’Shea JJ, Murray PJ. Cytokine signaling modules in inflammatory responses. Immunity. 2008 Apr;28:477–487.
   PubMed Web of Science ®Google Scholar
• Hart DA. Curbing inflammation in multiple sclerosis and endometriosis: should mast cells be targeted? Int J Inflamm. 2015;2015:1–10.
   Google Scholar
• Punchard NA, Whelan CJ, Adcock I. The journal of inflammation. J Inflamm Lond Engl. 2004 Sep;1:1.
   PubMedGoogle Scholar
• Futosi K, Fodor S, Mócsai A. Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int Immunopharmacol. 2013 Nov;17:638–650.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010 Mar;140:805–820.
   PubMed Web of Science ®Google Scholar
• Hall SC, Agrawal DK. Toll-like receptors, triggering receptor expressed on myeloid cells family members and receptor for advanced glycation end-products in allergic airway inflammation. Expert Rev Respir Med. 2016 Feb;10:171–184.
   PubMed Web of Science ®Google Scholar
• Nguyen AH, Koenck C, Quirk SK, et al. Triggering receptor expressed on myeloid cells in cutaneous melanoma: TREMs in melanoma. Clin Transl Sci. 2015 Oct;8:441–444.
   PubMed Web of Science ®Google Scholar
• Pelham CJ, Agrawal DK. Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases. Expert Rev Clin Immunol. 2014 Feb;10:243–256.
   PubMed Web of Science ®Google Scholar
• Klesney-Tait J, Turnbull IR, Colonna M. The TREM receptor family and signal integration. Nat Immunol. 2006 Dec;7:1266–1273.
   PubMed Web of Science ®Google Scholar
• Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001 Nov;294:1871–1875.
   PubMed Web of Science ®Google Scholar
• Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000 Aug;406:782–787.
   PubMed Web of Science ®Google Scholar
• Linehan SA, Martinez-Pomares L, Gordon S. Mannose receptor and scavenger receptor: two macrophage pattern recognition receptors with diverse functions in tissue homeostasis and host defense. Adv Exp Med Biol. 2000;479:1–14.
   PubMed Web of Science ®Google Scholar
• Genua M, Rutella S, Correale C, et al. The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis. J Transl Med [Internet]. 2014 Dec [cited 2015 Dec 14];12. Available from http://www.translational-medicine.com/content/12/1/293
   PubMed Web of Science ®Google Scholar
• Yuan Z, Syed MA, Panchal D, et al. Triggering receptor expressed on myeloid cells 1 (TREM-1)-mediated Bcl-2 induction prolongs macrophage survival. J Biol Chem. 2014 May;289:15118–15129.
   PubMed Web of Science ®Google Scholar
• Rigo I, McMahon L, Dhawan P, et al. Induction of triggering receptor expressed on myeloid cells (TREM-1) in airway epithelial cells by 1,25(OH)2 vitamin D3. Innate Immun. 2012 Apr;18:250–257.
   PubMed Web of Science ®Google Scholar
• Roe K, Gibot S, Verma S. Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity? Front Microbiol [Internet]. 2014 Nov [cited 2015 Dec 16];5. Available from: http://journal.frontiersin.org/article/10.3389/fmicb.2014.00627/abstract
   Google Scholar
• Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000 May;164:4991–4995.
   PubMed Web of Science ®Google Scholar
• Allcock RJN, Barrow AD, Forbes S, et al. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol. 2003 Feb;33:567–577.
   PubMed Web of Science ®Google Scholar
• Cantoni C, Bottino C, Vitale M, et al. NKp44, A triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 1999 Mar;189:787–796.
   PubMed Web of Science ®Google Scholar
• Won K-J, Park S-W, Lee S, et al. A new triggering receptor expressed on myeloid cells (TREM) family member, TLT-6, is involved in activation and proliferation of macrophages. Immune Netw. 2015;15:232.
   PubMed Web of Science ®Google Scholar
• Paradowska-Gorycka A, Jurkowska M. Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12. Hum Immunol. 2013 Jun;74:730–737.
   PubMed Web of Science ®Google Scholar
• Chung D-H, Seaman WE, Daws MR. Characterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17. Eur J Immunol. 2002 Jan;32:59–66.
   PubMed Web of Science ®Google Scholar
• Watarai H, Sekine E, Inoue S, et al. PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon. Proc Natl Acad Sci. 2008 Feb;105:2993–2998.
   PubMed Web of Science ®Google Scholar
• Radaev S, Kattah M, Rostro B, et al. Crystal structure of the human myeloid cell activating receptor TREM-1. Structure. 2003 Dec;11:1527–1535.
   PubMed Web of Science ®Google Scholar
• Klesney-Tait J, Colonna M. Uncovering the TREM-1-TLR connection. Am J Physiol Lung Cell Mol Physiol. 2007 Dec;293:L1374–L1376.
   PubMed Web of Science ®Google Scholar
• Call ME, Wucherpfennig KW, Chou JJ. The structural basis for intramembrane assembly of an activating immunoreceptor complex. Nat Immunol. 2010 Nov;11:1023–1029.
   PubMed Web of Science ®Google Scholar
• King RG, Herrin BR, Justement LB. Trem-like transcript 2 is expressed on cells of the myeloid/Granuloid and B lymphoid lineage and is up-regulated in response to inflammation. J Immunol. 2006 May;176:6012–6021.
   PubMed Web of Science ®Google Scholar
• Underhill DM, Goodridge HS. The many faces of ITAMs. Trends Immunol. 2007 Feb;28:66–73.
   PubMed Web of Science ®Google Scholar
• Hamerman JA, Jarjoura JR, Humphrey MB, et al. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol Baltim Md 1950. 2006 Aug;177:2051–2055.
   Google Scholar
• Van Bergen J, Koning F. The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR. Immunology. 2010 Nov;131:301–309.
   PubMed Web of Science ®Google Scholar
• Aguilar H, Álvarez-Errico D, García-Montero AC, et al. Molecular characterization of a novel immune receptor restricted to the monocytic lineage. J Immunol. 2004 Dec;173:6703–6711.
   PubMed Web of Science ®Google Scholar
• Martínez-Barriocanal A, Sayós J. Molecular and functional characterization of CD300b, a new activating immunoglobulin receptor able to transduce signals through two different pathways. J Immunol Baltim Md 1950. 2006 Sep;177:2819–2830.
   Google Scholar
• Cao H, Lakner U, De Bono B, et al. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur J Immunol. 2008 Aug;38:2303–2315.
   PubMed Web of Science ®Google Scholar
• Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol. 2009 Feb;21:38–46.
   PubMed Web of Science ®Google Scholar
• Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology. 2008 Nov;213:701–713.
   PubMed Web of Science ®Google Scholar
• Hamerman JA, Ni M, Killebrew JR, et al. The expanding roles of ITAM adapters FcRγ and DAP12 in myeloid cells. Immunol Rev. 2009 Nov;232:42–58.
   PubMed Web of Science ®Google Scholar
• Molloy EJ. Triggering receptor expressed on myeloid cells (TREM) family and the application of its antagonists. Recent patents anti-infect. Drug Disc. 2009 Jan;4:51–56.
   Google Scholar
• Bouchon A, Facchetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001 Apr;410:1103–1107.
   PubMed Web of Science ®Google Scholar
• Haselmayer P, Grosse-Hovest L, Von Landenberg P, et al. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood. 2007 Apr;110:1029–1035.
   PubMed Web of Science ®Google Scholar
• Wong-Baeza I, Gonzalez-Roldan N, Ferat-Osorio E, et al. Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol. 2006 Sep;145:448–455.
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Coberley SS, Olinger GG, et al. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and Ebola viruses. J Virol. 2006 Jul;80:7235–7244.
   PubMed Web of Science ®Google Scholar
• El Mezayen R, El Gazzar M, Seeds MC, et al. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett. 2007 Jul;111:36–44.
   PubMed Web of Science ®Google Scholar
• Tessarz AS, Cerwenka A. The TREM-1/DAP12 pathway. Immunol Lett. 2008 Mar;116:111–116.
   PubMed Web of Science ®Google Scholar
• Hommes TJ, Hoogendijk AJ, Dessing MC, et al. Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia: role of TREM-1 in pneumococcal pneumonia. J Pathol. 2014 Aug;233:357–367.
   PubMed Web of Science ®Google Scholar
• Arts RJW, Joosten LAB, Van Der Meer JWM, et al. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol. 2013 Feb;93:209–215.
   PubMed Web of Science ®Google Scholar
• Weber B, Schuster S, Zysset D, et al. TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. Modlin R, editor. PLoS Pathog. 2014 Jan;10:e1003900.
   PubMed Web of Science ®Google Scholar
• Zhang S-Y, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007 Sep;317:1522–1527.
   PubMed Web of Science ®Google Scholar
• Ornatowska M, Azim AC, Wang X, et al. Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. AJP lung cell. Mol Physiol. 2007 Sep;293:L1377–L1384.
   Google Scholar
• Hu L, Du Z, Zhao G, et al. Role of TREM-1 in response to Aspergillus fumigatus infection in corneal epithelial cells. Int Immunopharmacol. 2014 Nov;23:288–293.
   PubMed Web of Science ®Google Scholar
• Tessarz AS, Weiler S, Zanzinger K, et al. Non-T Cell Activation Linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells. J Immunol. 2007 Feb;178:1991–1999.
   PubMed Web of Science ®Google Scholar
• Janssen E, Zhu M, Zhang W, et al. LAB: A new membrane-associated adaptor molecule in B cell activation. Nat Immunol. 2003 Feb;4:117–123.
   PubMed Web of Science ®Google Scholar
• Brdicka T, Imrich M, Angelisová P, et al. Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. J Exp Med. 2002 Dec;196:1617–1626.
   PubMed Web of Science ®Google Scholar
• Hara H, Ishihara C, Takeuchi A, et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol. 2007 Jun;8:619–629.
   PubMed Web of Science ®Google Scholar
• Thome M, Weil R. Post-translational modifications regulate distinct functions of CARMA1 and BCL10. Trends Immunol. 2007 Jun;28:281–288.
   PubMed Web of Science ®Google Scholar
• Netea MG, Azam T, Ferwerda G, et al. Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. 1461 [Internet]. 2006 [cited 2015 Dec 28]. Available from: http://repository.ubn.ru.nl/handle/2066/51102
   Google Scholar
• Tomasello E, Vivier E. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Eur J Immunol. 2005 Jun;35:1670–1677.
   PubMed Web of Science ®Google Scholar
• Helming L, Tomasello E, Kyriakides TR, et al. Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal. 2008 Oct;1:ra11–ra11.
   PubMed Web of Science ®Google Scholar
• Zhang W, Huang S, Huang X, et al. Regulation of human mesenchymal stem cell differentiation by TREM-2. Hum Immunol [Internet]. 2015 Jun [cited 2015 Dec 29]. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0198885915001718
   Google Scholar
• Omar Sharif SK, Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology. 2008;213:701–713.
   PubMed Web of Science ®Google Scholar
• Sessa G, Podini P, Mariani M, et al. Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia. Eur J Neurosci. 2004 Nov;20:2617–2628.
   PubMed Web of Science ®Google Scholar
• Peng Q, Malhotra S, Torchia JA, et al. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal. 2010;3:ra38.
   PubMed Web of Science ®Google Scholar
• Turnbull IR, Colonna M. Activating and inhibitory functions of DAP12. Nat Rev Immunol. 2007 Feb;7:155–161.
   PubMed Web of Science ®Google Scholar
• Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol. 2009;27:591–619.
   PubMed Web of Science ®Google Scholar
• Fuller DM, Zhu M, C-W O-Y, et al. A tale of two TRAPs: LAT and LAB in the regulation of lymphocyte development, activation, and autoimmunity. Immunol Res. 2010 Dec;49:97–108.
   Web of Science ®Google Scholar
• Orr SJ, McVicar DW. LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes? J. Leukoc Biol. 2011 Jan;89:11–19.
   PubMed Web of Science ®Google Scholar
• Schwartzberg PL, Finkelstein LD, Readinger JA. TEC-family kinases: regulators of T-helper-cell differentiation. Nat Rev Immunol. 2005 Apr;5:284–295.
   PubMed Web of Science ®Google Scholar
• Abraham RT, Weiss A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat Rev Immunol. 2004 Apr;4:301–308.
   PubMed Web of Science ®Google Scholar
• Okkenhaug K, Ali K, Vanhaesebroeck B. Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3K. Trends Immunol. 2007 Feb;28:80–87.
   PubMed Web of Science ®Google Scholar
• Volná P, Lebduska P, Dráberová L, et al. Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL. J Exp Med. 2004 Oct;200:1001–1013.
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol. 2009 Apr;10:340–347.
   PubMed Web of Science ®Google Scholar
• Hamerman JA, Tchao NK, Lowell CA, et al. Enhanced toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol. 2005 Jun;6:579–586.
   PubMed Web of Science ®Google Scholar
• Kagan JC, Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling. Cell. 2006 Feb;125:943–955.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang H, Liu J, et al. Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study. Mediators Inflamm. 2014;2014:1–7.
   Web of Science ®Google Scholar
• Barraud D, Gibot S. Triggering receptor expressed on myeloid cell 1. Crit Care Clin. 2011 Apr;27:265–279.
   PubMed Web of Science ®Google Scholar
• Gomez-Pina V, Soares-Schanoski A, Rodriguez-Rojas A, et al. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol. 2007 Sep;179:4065–4073.
   PubMed Web of Science ®Google Scholar
• Gingras M-C, Lapillonne H, Margolin JF. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol. 2002 Mar;38:817–824.
   PubMed Web of Science ®Google Scholar
• Bishara J, Hadari N, Shalita-Chesner M, et al. Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults. Eur J Clin Microbiol Infect Dis. 2007 Aug;26:647–650.
   PubMed Web of Science ®Google Scholar
• Laj O, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013 Jan;493:346–355.
   PubMed Web of Science ®Google Scholar
• Wang R, Dillon CP, Shi LZ, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011 Dec;35:871–882.
   PubMed Web of Science ®Google Scholar
• Krawczyk CM, Holowka T, Sun J, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010 Jun;115:4742–4749.
   PubMed Web of Science ®Google Scholar
• Vazquez A, Liu J, Zhou Y, et al. Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. BMC Syst Biol. 2010;4:58.
   PubMed Web of Science ®Google Scholar
• Garedew A, Henderson SO, Moncada S. Activated macrophages utilize glycolytic ATP to maintain mitochondrial membrane potential and prevent apoptotic cell death. Cell Death Differ. 2010 Oct;17:1540–1550.
   PubMed Web of Science ®Google Scholar
• O’Connor W, Zenewicz LA, Flavell RA. The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol. 2010 Jun;11:471–476.
   PubMed Web of Science ®Google Scholar
• Shi LZ, Wang R, Huang G, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011 Jul;208:1367–1376.
   PubMed Web of Science ®Google Scholar
• Chang C-H, Curtis JD, Maggi LB, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013 Jun;153:1239–1251.
   PubMed Web of Science ®Google Scholar
• Gjw VDW, Everts B, Chang C-H, et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity. 2012 Jan;36:68–78.
   PubMed Web of Science ®Google Scholar
• Everts B, Amiel E, Gjw VDW, et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood. 2012 Aug;120:1422–1431.
   PubMed Web of Science ®Google Scholar
• J-C R-P, Través PG, Cuenca J, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol Baltim Md 1950. 2010 Jul;185:605–614.
   Google Scholar
• Vats D, Mukundan L, Odegaard JI, et al. Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab. 2006 Jul;4:13–24.
   PubMed Web of Science ®Google Scholar
• Rőszer T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm. 2015;2015:1–16.
   Web of Science ®Google Scholar
• Viollet B, Horman S, Leclerc J, et al. AMPK inhibition in health and disease. Crit Rev Biochem Mol Biol. 2010 Aug;45:276–295.
   PubMed Web of Science ®Google Scholar
• Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011 Sep;25:1895–1908.
   PubMed Web of Science ®Google Scholar
• Xiao B, Sanders MJ, Underwood E, et al. Structure of mammalian AMPK and its regulation by ADP. Nature. 2011 Apr;472:230–233.
   PubMed Web of Science ®Google Scholar
• Alessi DR, Sakamoto K, Bayascas JR. LKB1-dependent signaling pathways. Annu Rev Biochem. 2006;75:137–163.
   PubMed Web of Science ®Google Scholar
• Oakhill JS, Steel R, Chen Z-P, et al. AMPK is a direct adenylate charge-regulated protein kinase. Science. 2011 Jun;332:1433–1435.
   PubMed Web of Science ®Google Scholar
• Woods A, Dickerson K, Heath R, et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005 Jul;2:21–33.
   PubMed Web of Science ®Google Scholar
• Zmijewski JW, Banerjee S, Bae H, et al. Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem. 2010 Oct;285:33154–33164.
   PubMed Web of Science ®Google Scholar
• Salt IP, Palmer TM. Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation. Expert Opin Investig Drugs. 2012 Aug;21:1155–1167.
   PubMed Web of Science ®Google Scholar
• Pilon G, Dallaire P, Marette A. Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. J Biol Chem. 2004 May;279:20767–20774.
   PubMed Web of Science ®Google Scholar
• Giri S, Nath N, Smith B, et al. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J Neurosci Off J Soc Neurosci. 2004 Jan;24:479–487.
   PubMed Web of Science ®Google Scholar
• Cacicedo JM, Yagihashi N, Keaney JF, et al. AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2004 Nov;324:1204–1209.
   PubMed Web of Science ®Google Scholar
• Yang Z, Kahn BB, Shi H, et al. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem. 2010 Jun;285:19051–19059.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qiu J, Wang X, et al. AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. Arterioscler Thromb Vasc Biol. 2011 Dec;31:2897–2908.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang M, Liang B, et al. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res. 2010 Apr;106:1117–1128.
   PubMed Web of Science ®Google Scholar
• Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006 Mar;440:237–241.
   PubMed Web of Science ®Google Scholar
• Joosten LAB, Netea MG, Mylona E, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010 Nov;62:3237–3248.
   PubMed Web of Science ®Google Scholar
• Misawa T, Takahama M, Kozaki T, et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol. 2013 May;14:454–460.
   PubMed Web of Science ®Google Scholar
• Liu TF, Vachharajani VT, Yoza BK, et al. NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem. 2012 Jul;287:25758–25769.
   PubMed Web of Science ®Google Scholar
• Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J. 2004 Jun;23:2369–2380.
   PubMed Web of Science ®Google Scholar
• Kelly TJ, Lerin C, Haas W, et al. GCN5-mediated transcriptional control of the metabolic coactivator PGC-1β through lysine acetylation. J Biol Chem. 2009 Jul;284:19945–19952.
   PubMed Web of Science ®Google Scholar
• Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005 Jun;1:361–370.
   PubMed Web of Science ®Google Scholar
• Lan F, Cacicedo JM, Ruderman N, et al. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1 POSSIBLE ROLE IN AMP-ACTIVATED PROTEIN KINASE ACTIVATION. J Biol Chem. 2008 Oct;283:27628–27635.
   PubMed Web of Science ®Google Scholar
• Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009 Apr;458:1056–1060.
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Milne JC, Imamura T, et al. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol. 2009 Mar;29:1363–1374.
   PubMed Web of Science ®Google Scholar
• Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatol Oxf Engl. 2008 Apr;47:409–414.
   PubMed Web of Science ®Google Scholar
• Jeong HW, Hsu KC, Lee J-W, et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab. 2009 Apr;296:E955–E964.
   PubMed Web of Science ®Google Scholar
• Nerstedt A, Johansson A, Andersson CX, et al. AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3). Diabetologia. 2010 Nov;53:2406–2416.
   PubMed Web of Science ®Google Scholar
• Kim YD, Kim YH, Cho YM, et al. Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models. Diabetologia. 2012 May;55:1482–1494.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang M, Liang B, et al. Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. Plos One [Internet]. 2011 Sep [cited 2016 Jan 5];6. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181327/
   Google Scholar
• Lumeng CN, DelProposto JB, Westcott DJ, et al. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes. 2008 Dec;57:3239–3246.
   PubMed Web of Science ®Google Scholar
• Davies SP, Sim ATR, Hardie DG. Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase. Eur J Biochem. 1990 Jan;187:183–190.
   PubMedGoogle Scholar
• Kukidome D, Nishikawa T, Sonoda K, et al. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes. 2006 Jan;55:120–127.
   PubMed Web of Science ®Google Scholar
• Galic S, Fullerton MD, Schertzer JD, et al. Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest. 2011 Dec;121:4903–4915.
   PubMed Web of Science ®Google Scholar